ARTICLE | Company News

Management tracks: PlaqueTec, Biohaven

November 13, 2017 11:27 PM UTC

Liquid biopsy play PlaqueTec Ltd. (Cambridge, U.K.) named Annalisa Jenkins CEO. She was president and CEO of Dimension Therapeutics Inc., which Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) acquired. Jenkins succeeds Tim Brears.

Neurology company Biohaven Pharmaceutical Holding Co. Ltd. (NYSE:BHVN) hired Scott Phillips as SVP of finance. He was SVP of global business finance and chief accounting officer at Alexion Pharmaceuticals Inc. (NASDAQ:ALXN)...